GHRL and chronic obstructive pulmonary disease: SUN11031, a ghrelin agonist with a longer half-life than ghrelin, was used in a clinical trial of cachexia associated with chronic obstructive pulmonary disease and found to increase the muscle mass of patients, though no apparent improvement of muscle function was detected during the short period of observation [21].